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TraI, a bifunctional enzyme containing relaxase and helicase
activities, initiates and drives the conjugative transfer of the
Escherichia coli F plasmid. Here, we examined the structure and
function of the TraI helicase.We show that TraI binds to single-
stranded DNA (ssDNA) with a site size of 25 nucleotides,
which is significantly longer than the site size of other known
superfamily I helicases. Lowcooperativitywas observedwith the
binding of TraI to ssDNA, and a double-stranded DNA-binding
site was identified within the N-terminal region of TraI 1–858,
outside the core helicase motifs of TraI. We have revealed that
the affinity of TraI for DNA is negatively correlated with the
ionic strength of the solution. The binding of AMPPNP or ADP
results in a 3-fold increase in the affinity of TraI for ssDNA.
Moreover, TraI prefers to bind ssDNA oligomers containing a
single type of base. Finally, we elucidated the solution structure
of TraI using small angle x-ray scattering. TraI exhibits an ellip-
soidal shape in solution with four domains aligning along one
axis. Taken together, these data result in the assembly of amodel
for the multidomain helicase activity of TraI.
Conjugative plasmid transfer is a central mechanism for the
horizontal exchange of geneticmaterial between bacterial cells,
as well as for the spread of antibiotic resistance genes and viru-
lence factors (1–3). Conjugative plasmid transfer requires both
aDNArelaxase and aDNAhelicase. The relaxase initiatesDNA
transfer by cleaving the transferred strand at a specific site
within the oriT, forming a 5-phosphotyrosine intermediate.
Following nicking, the helicase uses the energy from ATP
hydrolysis to unwind the plasmid and drive the transfer of DNA
into the recipient cell. The relaxase completes plasmid transfer
by breaking the covalent phosphotyrosine linkage and releasing
the transferred DNA for replication in the recipient (2, 4, 5).
The relaxase and helicase activities necessary for F plasmid
transfer are located on a 190-kDamultidomain protein, TraI (6,
7). TraI requires the assistance of two additional F plasmid-
encoded proteins, TraY and TraM, as well as integration host
factor for conjugative transfer. These four proteins bind to the
500-bp oriT site and form a protein complex called the relaxo-
some (2). TraI contains three major functional domains,
including the N-terminal relaxase domain (residues 1–309), a
central helicase domain (residues 310 to 1476), and a C-termi-
nal domain (CTD,4 residues 1477–1756) that is responsible for
interactions with TraY and TraM (Fig. 1) (8–11). The region
between residues 310 and 950 is not fully characterized,
although it has been proposed to share a helicase-like fold (see
below). The covalent linkage between these functional domains
is required for efficient conjugation (12).
TraI is a superfamily I helicase with ssDNA-dependent
NTPase and helicase activities (13, 14). The translocation of
TraI along DNA has 5 to 3 polarity (15, 16). TraI requires a 5
single-stranded overhang for the initiation of DNA unwinding
(15). In addition, TraI functions as a highly processive helicase
as a monomer (14). Unlike other helicases, the processivity of
TraI helicase requires neither oligomerization nor the presence
of a processivity factor. The underlying mechanism of the pro-
cessivity of TraI has remained unclear (14).
Although the interaction of TraI with DNA is essential to its
helicase activity, little is known about the DNA-binding prop-
erties of the TraI helicase. Matson and co-workers (8) showed
that deletion of the region 309–349 disrupts helicase-associ-
ated ssDNAbinding and the helicase activity. Recentwork from
Dostal and Schildbach (17) suggested that the helicase domain
of TraI consists of two RecD-like subdomains (Fig. 1). The
C-terminal RecD-like domain (residues 830–1473) contains
helicase motifs and is the motor domain, whereas the N-termi-
nal RecD-like domain (residues 303–844) lacks critical helicase
motifs and likely specializes in ssDNA binding (17). Numerous
fundamental aspects of the interaction of the TraI helicase with
DNA, such as the length of DNA bound by TraI, the intrinsic
binding affinity, binding cooperativity, dependence of affinity
on ionic strength, nucleotide binding, and base specificity, are
still unclear. This knowledge is important for the quantitative
understanding of the interaction between TraI helicase and
DNA, as well as the molecular mechanism and regulation of
TraI helicase activity.
Here, we used fluorescence anisotropy-based equilibrium
binding assays to investigate TraI helicase-associated DNA-
binding properties. Our studies have elucidated the intrin-
sic binding affinity, binding cooperativity, and the lengths of
ssDNA and dsDNAbound by TraI. Also, we identified the loca-
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tion on TraI of the dsDNAbinding site. Furthermore, we inves-
tigated the effect of ionic strength, nucleotide binding, and base
composition on the affinity of TraI for DNA. Finally, we exam-
ined the spatial organization of TraI domains in solution.
Together, these results advance our understanding of the inter-
action between TraI helicase and DNA, providing insights into
the molecular mechanism by which TraI performs its helicase
function.
EXPERIMENTAL PROCEDURES
DNA Oligomers—DNA oligomers used in this study were
purchased from Integrated DNA Technology (IDT, Coralville,
IA). Labeled oligomers have the fluorescent probe 6-FAMTM
covalently attached to their 5 end and were purified using
HPLC by IDT. Unlabeled oligomers were desalted without fur-
ther purification. The sequences of DNAoligomers are listed in
Table 1. All DNA oligomers were dissolved in oligomer anneal-
ing buffer containing 50mMTris-HCl, pH8.0, 50mMNaCl, and
5 mM MgCl2. To prepare duplex DNA, two complementary
DNA oligomers were mixed in a 1:1 molar ratio, heated to
95 °C, and slowly cooled down to 20 °Cwith a speed of 1 °C/min
in a thermocycler.
DNA Binding Buffers—Standard DNA binding buffer con-
tained 25 mM Tris-HCl, pH 7.5, 100 mM NaCl, 5 mM magne-
sium acetate, and 0.1% BSA. Buffer A contained 25 mM Tris-
HCl, pH 7.5, 50 mM NaCl, 5 mM magnesium acetate, and 0.1%
BSA. Buffer B contained 50mMTris-HCl, pH7.5, 100mMNaCl,
5 mMmagnesium acetate, and 0.1% BSA. Buffer C contained 25
mM Tris-HCl, pH 7.5, and 0.1% BSA.
Protein Constructs, Expression, and Purification—Standard
ligation independent cloning techniques, as described by Stols
et al. (18), were employed in the construction of expression
plasmids encoding the segments of TraI used in this study. The
amplified DNA fragments were treated and cloned into empty
pMCSG7-Lic-MBP expression vector (18). The His6 maltose-
binding protein tag was cleaved off after purification using
tobacco etch virus protease. All expression plasmids used in
this study were sequence-verified.
The expression plasmids were transformed into Escherichia
coli BL21 (DE3) Gold (Stratagene). Bacteria were grown in LB
medium supplemented with 50 g/ml ampicillin at 37 °C with
shaking. After the A600 reached 0.6, isopropyl -D-thiogalacto-
side was added to a final concentration of 0.2 mM, and bacteria
were grown for another 12 h at 16 °C with shaking. Bacteria
were harvested and resuspended in loading buffer (50 mM
sodium phosphate, pH 7.6, 500 mM NaCl, 25 mM imidazole)
supplemented with 0.5 mM EDTA, 0.1% Triton X-100, 1 mM
PMSF, 1 tablet of a protease inhibitor mixture (Roche Applied
Science), and 1 mg/ml lysozyme. After 1 h of incubation on ice,
the resuspended cells were sonicated on ice for 2 min, and the
lysate was centrifuged at 45,000  g for 90 min at 4 °C. The
supernatant was passed through a 0.2-m filter (Millipore) and
then loaded onto a 5-ml high performance HisTrapTM column
(GE Healthcare), equilibrated with loading buffer. The column
was washed with 100ml of loading buffer before bound protein
was eluted with elution buffer (50 mM sodium phosphate, pH
7.6, 500 mM NaCl, 500 mM imidazole). The eluted protein was
pooled and loaded onto a HiPrepTM 26/10 desalting column
(GEHealthcare) equilibratedwith desalting buffer (20mMTris-
HCl, pH 8.0, 150 mM NaCl, 1 mM DTT, and 0.5 mM EDTA).
Fractions containing protein were collected. Tobacco etch
virus protease was added to the pooled protein fractions with a
ratio of 1:100 (w/w) tobacco etch virus to TraI. After 16 h of
incubation at 4 °C, the mixture was reloaded onto a 5-ml
HisTrapTM column equilibrated with loading buffer. The flow-
through fractions were collected and concentrated in a Centri-
con YM30 (Amicon) concentrator. Finally, concentrated pro-
tein was loaded on a HiLoadTM 16/60 Superdex 200 column
(GE Healthcare) equilibrated with sizing buffer (20 mM Tris-
HCl, pH 7.5, 100 mM NaCl, 5% glycerol). Protein-containing
fractions were concentrated, flash-frozen in liquid nitrogen,
and stored at 80 °C. Purified protein was 95% pure by
SDS-PAGE.
Small Angle X-ray Scattering (SAXS) and Data Analysis—
SAXS data were collected for protein solutions and their
matched buffers using the standard SAXS instrument at the
beamline 18-ID (Bio-CAT,Advanced Photon Source, Argonne,
IL). The experiments were carried out at 16 °C using an x-ray
photon energy of 12 keV. The Mar165 CCD detector with an
active area of160 80mm2was used for data collection. The
sample-to-detector distances were set to 2.3m tomake scatter-
ing vectors, q, range from 0.007 to 0.38 Å1. The scattering
vector here is defined as q  4sin/, where 2 is the scatter-
ing angle. Samples were flowed back and forth during SAXS
measurements with a Hamilton programmable syringe pump
tominimizeradiationdamage.Twenty framesof shortexposure (2
s) were taken on each sample and averaged to improve the signal/
noise ratio. Data were reduced using Bio-CAT SAXS data reduc-
tionmacros installed in theprogramIgor (WaveMetrics, Portland,
OR). Guinier plots, made using the program Igor, were used for
detection of aggregation in protein samples. Guinier approxima-
tion I(q) I(0) exp(q2Rg2/3)with the limitsqRg1.3wasused to
determine the radius of gyration, Rg, and the scattering intensity
extrapolated to zero angle I(0). The molecular weight of TraI was
determined from I(0) on a relative scale using cytochrome c as a
reference. The pair distribution function, P(r), and the maximum
dimension of the protein, Dmax, were computed by the program
GNOM (19).
Ab Initio Shape Restoration and Structural Modeling—The
low resolution shape of TraI was restored from the experimen-
tal SAXS profile using the program DAMMIN (20). The data
within the q range of 0.0104 to 0.2129 Å1 were used for the
analysis. Forty individual models were generated by DAMMIN
(21). The 20 models with the best 2 were aligned using
SUBCOMB and averaged using DAMMAVER (21). The aver-
aged model was then filtered based on occupancy and volume
using DAMFILT to generate the final model of TraI. The volu-
metric representation of the SAXS model was prepared by
SITUS (22).
Crystal structures of the relaxase domain (residues 1–307)
and the C-terminal domain (residues 1476–1628) were ob-
tained fromProtein Data Bank (PDB) using the accession num-
bers 1P4D and 3FLD, respectively. Homology models of TraI
309–842 and TraI 846–1473 were constructed by PHYRE (23)
using the crystal structure of RecD from E. coli RecBCD com-
plex (PDB accession number 1W36) as a template. The atomic
TraI Relaxase-Helicase
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models were placed into the ab initio shape by visual judgment
using the program Chimera (24). The scattering intensities of
the structural model were calculated using CRYSOL (25). The
goodness of the structural model was assessed by CRYSOL
based on the discrepancy (2) between the calculated scattering
intensities and the experimental scattering intensities. The ori-
entation and position of individual domains in the structural
model were manually adjusted to minimize the discrepancy.
Direct DNA Binding Assays—Fluorescence anisotropy (FA)-
based DNA binding assays were employed to study DNA bind-
ing by TraI as described by Shildbach and co-workers (26) with
somemodifications. To perform the direct DNA binding assay,
a 6FAM-labeledDNAoligomerwasmixedwith increasing con-
centrations of protein in DNA binding buffer in 384-well plates
(Corning Glass). The fluorescence anisotropy of each well was
measured by a Pherastar plate reader (BMG Labtech, Offen-
burg, Germany) using the excitation and emission wavelengths
of 485 and 520 nm, respectively. The fluorescence anisotropy
(FA) was defined as shown in Equation 1,
FA  Ivv 	 Ivh	Ivv 
 2Ivh	 (Eq. 1)
where Ivv and Ivh represent the fluorescence intensity signal
parallel and perpendicular to the excitation polarization. All
experiments were done in triplicate. To calculate the macro-
scopic DNA binding constant (KN), normalized data were plot-
ted as average FA versus total protein concentration and fit to
Equation 2,
FA  FAmin 
 FAmax 	 FAmin	
DT 
 x 







using nonlinear regression in SigmaPlot 11.0 (Systat Software,
Inc.), where FA is the observed FA signal; FAmin is the FA signal
in the absence of protein; FAmax is the FA signal in the presence
of saturating concentration of protein; DT is the total concen-
tration of 6FAM-labeled DNA; x is the total protein concentra-
tion; and KN is the macroscopic binding constant. The error
bars represent the standard deviation of three replicates.
Macromolecule Competition Titration (MCT) Method—The
binding of TraI to unlabeled DNA oligomers was investigated
using the MCT method as described by Jezewska and
Bujalowski (27). In brief, a 6FAM-labeled reference DNA olig-
omer (total concentration, DTR) was mixed with increasing
concentrations of protein in DNA binding buffer in 384-well
plates in the presence of a competing unlabeled DNA oligomer
(total concentration,DTS). The fluorescence anisotropy of each
well was measured using a Pherastar plate reader with the exci-
tation and emission wavelengths of 485 and 520 nm, respec-
tively. The total protein concentration in the presence of a com-
peting DNA oligomer, PT1, was defined as Equation 3,
PT1  
 i	R DTR 
 
 i	S DTS 
 PF (Eq. 3)
where (i)R, (i)S, and PF represent the binding density of
the protein on the fluorescent DNA oligomer, the binding den-
sity on the unlabeled competing DNA oligomer, and the free
protein concentration, respectively. In the absence of a compet-
ing DNA oligomer, Equation 3 can be simplified as shown in
Equation 4,
PT  
 i	R DTR 
 PF (Eq. 4)
When the same FA signal is observed in the absence and in the
presence of a competing DNA oligomer, the binding density of
the protein on the unlabeled competingDNAoligomer, defined
as Equation 5, can be derived by solving the set of Equations 3
and 4.

 i	S  PT1 	 PTDTS (Eq. 5)
When (i)S is known, PF can be obtained by using Equation 6,
PF  PT1 	 
i	S DTS 	 
i	R DTR (Eq. 6)
The binding stoichiometry is equal to the value of (i)S when
FA reaches its maximum, as determined from the plot of FA
versus (i)S.
Determination of the Binding Parameters—The model-inde-
pendent and thermodynamically rigorous binding isotherm
can then be constructed by plotting (i)S against PF. The
binding isotherms were analyzed using the Epstein combinato-
rial approach for binding of a protein to a linear nucleic acid
(28). The relation between (i) and PF can be expressed as
Equations 7 and 8,
FIGURE 1. Schematic representations of the domain organization of TraI and the TraI constructs used in this study. The N-terminal relaxase domain
contains residues 1–309; helicase domain contains residues 310 –1476, and the CTD contains residues 1477–1504. The asterisk indicates the location of the
catalytic residue Lys-998. RecD-like domain I (residues 303– 844) and RecD-like domain II (residues 830 –1473) identified by sequence analysis (17) are high-
lighted by dark lines. TraI constructs are shown in open boxes, whose first and last residues are indicated.
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(Eq. 8)
Where k is the number of protein bound per nucleic acid; g is
the maximum number of k; N is the total length of the nucleic
acid;m is the size of nucleic acid-binding site; Kint is the intrin-
sic binding constant;  is the cooperativity parameter, and j is
the number of cooperative contacts formed between protein
molecules bound to the nucleic acid. The combinatorial factor
PN (k, j) defines the number of distinct ways that k protein
molecules, each of which form j cooperative contacts, can bind
to a nucleic acid.
When the nucleic acid can maximally bind one protein mol-
ecule, Equations 7 and 8 can be simplified as Equations 9 or 10,

 i	  N 	 m 
 1	 KintPF1 
 N 	 m 
 1	 K intPF (Eq. 9)

 i	  KNPF1 
 KNPF (Eq. 10)
Competition Binding Assay—A 6FAM-labeled DNA olig-
omer was used as the reference DNA. Protein was mixed with
the reference DNA and titrated with increasing concentrations
of an unlabeled DNA oligomer (the competitor DNA). The
decrease in fluorescence anisotropy values with the titration of
the competitor DNA was monitored. The IC50, or the concen-
tration of competitor DNA required to displace 50% of the
complex formed by protein and reference DNA, was deter-
mined by plotting the anisotropy value as a function of compet-
itor DNA concentration and fitting the curve using Equation
11.
FIGURE 2. Determination of the stoichiometry of ssDNA binding by TraI.
Titration of 50 nM FL-T17 with TraI was performed in the presence or absence
of 200 nM Tn (n ranges from 13 to 31) (A) and 350 nM 39-, 45-, 51-, and 63-mer
ssDNA (B) in standard DNA binding buffer at 25 °C. The solid lines are used to
separate the data and do not have any theoretical basis. C, dependence of
observed anisotropy on the total averaged binding density of TraI on the
39-mer. This plot was constructed based on the titration curve in B using
the MCT analysis (27). The short solid line indicates the maximum value of the
observed anisotropy. The stoichiometry was estimated to one TraI molecule
per 39-mer from this plot.
TABLE 1
Sequences of DNA oligomers used in this study
6FAM, or 6-carboxyfluorescein, is a fluorescent probe that is covalently attached to
the 5 end of DNA oligomers. The subscript indicates the length of the DNA
oligomer. For a double-strandedDNA (dsDNA) oligomer, the sequence of the com-











FL-dsDNA15 6FAM-5-TCG GAT CGC AGT CAG-3
dsDNA9 5-TCG GAT CGC-3
dsDNA11 5-TCG GAT CGC AG-3
dsDNA15 5-TCG GAT CGC AGT CAG-3
dsDNA19 5-TCG GAT CGC AGT CAG ACG G-3
dsDNA21 5-TCG GAT CGC AGT CAG ACG GTC-3
dsDNA23 5-TCG GAT CGC AGT CAG ACG GTC AG-3
dsDNA27 5-TCG GAT CGC AGT CAG ACG GTC AGT GAC-3
TraI Relaxase-Helicase
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 10log IC50 	 x	
(Eq. 11)
RESULTS
The interaction between protein and DNA can be studied
conveniently by quantitative titrations of a fluorescently labeled
DNAwith the protein of interest. However, the binding param-
eters obtained in this manner are often inaccurate due to the
interference from the fluorescent probe. To understand the
intrinsic DNA-binding property of TraI, we have studied
the interaction ofTraIwith unlabeledDNAoligomers using the
MCTmethod as described by Jezewska andBujalowski (27) (see
also “Experimental Procedures”). This method has been suc-
cessfully applied to the analysis of the interactions of the PriA
and RepA helicases with DNA (29, 30). In brief, a fluorescently
labeled DNA oligomer, or the reference DNA, is titrated with
TraI in the absence or presence of an unlabeled DNA oligomer,
or the competing DNA, whose binding parameters are to be
determined. Because the association of the unlabeled ssDNA
oligomer with TraI does not give significant anisotropy signal,
the presence of the unlabeled DNA oligomer will shift the titra-
tion curve to higher TraI concentration as compared with the
curve generated in the absence of competitor. Based on the shift
of the titration curve, this method allows the determination of
the binding stoichiometry of TraI with an unlabeled DNA olig-
omer. The MCT method also enables the construction of a
model-independent binding isotherm, which can be used for
the determination of thermodynamically rigorous binding
parameters for the unlabeled DNA oligomer. The protein con-
structs and DNA oligomers used for this study are listed in
Fig. 1 and Table 1 respectively.
Binding of TraI Helicase to ssDNA: Determination of the Site
Size and DNA Binding Parameters—The interaction of TraI
with a series of unlabeled ssDNA oligomers of different lengths
was studied using the MCT method (27). Titration of 50 nM
FL-T17 (fluorescently labeled T17) with TraI in the absence or
presence of 200 or 350 nM ssDNA oligomers of lengths ranging
from 13 to 63 nucleotides were conducted in standard DNA
binding buffer (Fig. 2, A and B). The unlabeled 13-, 15-, and
17-mer ssDNA did not cause significant shift of the titration
curves to higher TraI concentration, suggesting that TraI can-
not bind tightly to unlabeled 13-, 15-, and 17-mer under our
assay conditions.
The binding stoichiometry of TraI with the 39-mer was
determined by examining the dependence of anisotropy values
on the binding density from the titration curves (Fig. 2C). The
binding stoichiometry of TraI with the 39-merwas estimated to
be one, because binding density equaled one at the maximum
anisotropy value of 291. Analogous analyses of the binding stoi-
chiometry were performed for DNA oligomers varying in
length from 17 nucleotides to 63 nucleotides (data not shown).
The dependence of maximum stoichiometry on the length of
ssDNA oligomers indicated that 51- and 63-mers can accom-
modate two TraI molecules, whereas ssDNA oligomers shorter
than 45 nucleotides can only accommodate one TraI molecule.
To determine the binding parameters of TraI for the ssDNA
oligomers, we constructed a model-independent binding iso-
FIGURE 3. Determination of binding parameters for TraI binding to
ssDNA. A, model-independent binding isotherms of TraI to unlabeled ssDNA
Tn (n ranges from 19 to 31). The binding density and the corresponding con-
centration of free TraI were calculated from the titration curve in Fig. 2A using
the MCT analysis (27). The solid lines are computer fits of the data using Equa-
tion 9 under the condition m  25 or Equation 10. The macroscopic binding
constants (KN) and intrinsic binding constants (Kint) derived from curve-fitting
are summarized in Table 2. B, model-independent binding isotherm of TraI to
63-mer ssDNA. The solid line is computer fit of the data using the Epstein
combinatorial approach (Equations 7 and 8) under the condition m  25
and g  2. The best fit gives Kint  6.7(0.2) 10
5
M
1 and   33.4  2.4.
C, dependence of KN on the length of the ssDNA oligomers. The solid line is
the linear fit of the data points for T25, T27, T29, and T31.
TraI Relaxase-Helicase
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therm for each ssDNA oligomer. Because ssDNA 13-, 15-, and
17-mer did not create a significant shift in the titration curve,
their binding isotherms could not be accurately determined.
The binding isotherms for the 19-mer and longer oligomers are
shown in Fig. 3, A and B. The macroscopic binding constants
(KN) for 31-mer and below were determined by analyzing the
binding isotherms with Equation 10 because these DNA olig-
omers can only accept one TraI molecule; the results are sum-
marized in Table 2. The dependence of KN on the length of
ssDNAoligomers (N) can be clearly divided into two phases.KN
increased relatively slowly whenN 25 but faster whenN25.
A roughly linear relationship between KN and N was observed
when N ranges from 25 to 31 nucleotides (Fig. 3C). An expla-
nation for this linear relationship is that TraI experiences mul-
tiple potential binding sites on an ssDNA longer than 25 nucle-
otides, indicating that the ssDNA-binding site size of TraI is
about 25 nucleotides. The observed dramatic increase in KN
was caused by a statistical factor arising from the existence of
multiple potential binding sites, instead of the formation of
more contacts between TraI and ssDNA oligomers (28, 31, 32).
This statistical factor can be defined in terms of the intrinsic
binding constant (Kint) and the total site size (m) (29, 30) as
shown in Equation 12.
KN  N 	 m 
 1	 K int (Eq. 12)
This empirical linear relationship usually appears only when
the length of theDNAoligomer is longer than the total site size.
In contrast, the slow increase of KN withN, whenN 25, likely
reflects the formation of increasing contacts between TraI and
DNA. The intrinsic binding constants (Kint) for the ssDNA that
bind oneTraImoleculewere determined by analyzing the bind-
ing isotherms in Fig. 3A using Equation 9 under the condition
m  25. The results were summarized in Table 2. The Kint did
not change significantly with the length of the ssDNA oligom-
ers, ranging from 1.8  0.5 to 2.6  0.3  107 M1. This result
supports the estimation of the total site size to be 25
nucleotides.
Because the total site size is 25 nucleotides, complete
engagement of the ssDNA-binding site of two TraI molecules
should require ssDNA of at least 50 nucleotides. To determine
the cooperativity parameter () for TraI binding to ssDNA,
we analyzed the interaction of TraI with the ssDNA 63-mer.
The corresponding binding isotherm, shown in Fig. 3B, was
analyzed using the Epstein equation under the condition
m  25 and g  2. The Kint and  were determined to be 6.7
(0.2) 105 M1 and 33.4 () 2.4, respectively. Our data
clearly indicate that TraI binds to ssDNA oligomers with low
cooperativity.
Binding of TraI to dsDNA, Determination of the Site Size and
Binding Parameters—We next examined the interaction of
TraI with unlabeled dsDNAusing theMCTmethod (27). Titra-
tion of 100 nM FL-dsDNA15 with TraI in the absence or pres-
ence of 500 nM unlabeled dsDNA oligomers of length ranging
from 9 to 27 bp in buffer A was performed (Fig. 4A). Oligomers
shorter than 9 bp were not studied here because they have low
melting temperatures and are unstable at the temperature of
the experiment (25 °C). The binding stoichiometry of TraI with
dsDNA15 was estimated from the plot of fluorescence anisot-
ropy versus binding density as described above (Fig. 4B). Anal-
ogous analyses were performed to determine the binding stoi-
chiometry of TraI with other dsDNA oligomers (data now
shown). Our results show that the 19-, 23-, and 27-mer dsDNA
can accept two TraI molecules, whereas 11- and 15-mer
dsDNAcan only bind oneTraImolecule (Table 3). The fact that
a 19-mer, but not a 15-mer, dsDNAcan accommodate twoTraI
molecules indicates that each TraI molecule encompasses at
least 8–9 bp when forming a stable complex with a dsDNA.
Next, the intrinsic binding constant (Kint) was determined by
fitting the binding isotherms (Fig. 4C) with the Epstein equa-
tion under the conditions that the site sizem  9 and the max-
imum binding density g  1 (for 9-, 11-, and 15-mer) or g  2
(for 19-, 23-, and 27-mer). These results are summarized in
Table 3. The large error in Kint for the 9-mer resulted from the
low binding density of TraI on the 9-mer under our assay con-
ditions (Fig. 4C). Our data show that TraI has a similar Kint for
dsDNA of lengths ranging from 11 to 27 bp, supporting the
hypothesis that TraI contacts 9 bp when it forms a complex
with dsDNA. TraI does not bind dsDNA oligomers in a highly
cooperative fashion, as evidenced by  values ranging from
14.8 2.2 to 38.6 7.7 for dsDNA ranging in length from 19 to
27 bp.
Identification of the dsDNA-binding Site—To identify the
dsDNA-binding site, we designed a series of TraI constructs
based on the proposed domain organization of TraI (Fig. 1) and
examined their interaction with FL-dsDNA15 using the direct
DNA binding assay (Fig. 5A) (26). Macroscopic binding con-
stants,KN, were determined by fitting the titration curves using
a one-site binding model (Equation 2) and are summarized in
Table 4. The affinity of TraI 1–1476 and TraI 1–858 for FL-
dsDNA15 were comparable with that of full-length TraI, sug-
gesting that the dsDNA-binding site is located N-terminal to
residue 858. TraI 1–330, a construct that contains the relaxase
domain, cannot bind FL-dsDNA15 under our assay condition
(Fig. 5A). However, the deletion of residues 1–301 dramatically
reduced the affinity of TraI for FL-dsDNA15. The binding affin-
ity of TraI 302–1756 for FL-dsDNA15 is about 20-fold lower
TABLE 2
Thermodynamic parameters of TraI binding to ssDNA oligomers of length ranging from 19 to 31 nucleotides in standard DNA binding buffer at
25 °C
The following abbreviations are used: n, stoichiometry; KN, macroscopic binding constant; Kint, intrinsic binding constant; NA, not applicable.
T19 T21 T23 T25 T27 T29 T31
n 1 1 1 1 1 1 1
KN 107 (M 1) 0.9  0.1 1.6  0.1 2.5  0.1 2.6  0.3 6.2  0.3 10  1 12  1
Kint  107 (M 1) NA NA NA 2.6  0.3 2.1  0.1 2.1  0.1 1.8  0.5
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than that of full-length TraI. These results indicate that
although the dsDNA-binding site is primarily located between
residues 302 and 858, the relaxase domain facilitates the bind-
ing of dsDNA.
A helicase-associated ssDNA-binding site is located at the
N-terminal region of TraI 302–820 (17). Therefore, it is possi-
ble that the dsDNA-binding site identified here overlaps with
the ssDNA-binding site. To test this possibility, we performed a
competition binding assay using FL-dsDNA15 as the reference
DNA and the ssDNA oligomer T25 as the competitor DNA.
Under our experimental conditions, a complex of TraI with
FL-dsDNA15, but not with T25, can generate a fluorescence ani-
sotropy signal. If T25 effectively competes with FL-dsDNA15 for
the dsDNA-binding site of TraI, the total anisotropy value will
drop with an increase in the concentration of T25. Indeed, the
total anisotropy value decreased with the increase of T25 con-
centration with an apparent IC50 of 1.5 M (Fig. 5B). This sug-
gests that the binding of T25 and FL-dsDNA15 by TraI occurs
along an overlapping if not identical binding surface.
Modulation of DNA Binding Affinity by Nucleotides—We
evaluated the effect of nucleotides on the affinity of TraI for
unlabeled ssDNA oligomers using the MCT method (27).
Titration of 50 nM FL-T17 with TraI in the absence or presence
of T25 and in the absence or presence of ADP or the nonhydro-
lyzable ATP analogAMPPNPwas performed in buffer B (Fig. 6,
A–C), and a model-independent binding isotherm was con-
structed (Fig. 6D). The Kint for T25 in the absence of any nucle-
otides was determined to be 2.8 (0.4)  107 M1 by analyzing
the binding isothermusing Equation 9 under the conditionm
25. Because TraI can slowly hydrolyze ATP in the presence of
T25 under our assay conditions, the nonhydrolyzable ATP ana-
log (AMPPNP) was used instead of ATP. The presence of 1 mM
ADP or AMPPNP increased the Kint of TraI for T25 to 1.2
(0.3)  108 and 1.4 (0.4)  108 M1, respectively. These
results demonstrate that the binding of ADP and AMPPNP
slightly enhances the affinity of TraI for ssDNA.
Effect of Ionic Strength on DNA Binding—To further define
the DNA-binding properties of TraI, we examined the effect of
ionic strength on the affinity of TraI for ssDNA and dsDNA
using the direct DNA binding assay (26). Titration of 50 nM
FL-T25 was performed in buffer C supplemented with increas-
ing concentrations of NaCl: 50, 75, 100, and 125 mM. To avoid
the interference of Mg2, buffer C did not contain magnesium
acetate and was supplemented with 1 mM EDTA. Analogous
experiments were performed for FL-dsDNA15. The affinity of
TraI for ssDNA and dsDNA decreased with the increase of
NaCl concentration (Fig. 7A). The Kint for FL-T25 is 1.1
(0.3) 108 M1 when [NaCl] 50mM. A 3.4-fold decrease in
Kint was observed when [NaCl] was increased to 125 mM NaCl.
More dramatic change in Kint was observed with FL-dsDNA15,
withKint decreasing about 36-fold when [NaCl] increased from
50 to 125 mM (Fig. 7A). Within experimental error, a linear
relationship between ln(Kint) and ln[NaCl] was detected for
both FL-T25 and FL-dsDNA15, with slopes of 1.2  0.2 and
FIGURE 4. Determination of stoichiometry and binding parameters for TraI
binding to dsDNA. A, titration of 100 nM FL-dsDNA15 with TraI was performed in
the absence or presence of 500 nM dsDNA of different lengths (ranging from 9 to
27 residues) in buffer A at 25 °C. The solid lines are used to separate the data and
do not have any theoretical basis. B, dependence of observed fluorescence ani-
sotropy on the total averaged binding density of TraI on the 15-mer dsDNA. The
short solid line indicates the maximum value of the observed anisotropy.
C, model-independent binding isotherms of TraI to unlabeled dsDNA of different
lengths, ranging from 9 to 27 bp. The binding density and the concentration of
free TraI were calculated from the titration curves in A using the MCT analysis (27).
The solid lines are computer fits of the data using the Epstein combinatorial
approach (Equations 7 and 8). The parameters were m  9 and g  1 for dsDNA9,
dsDNA11, and dsDNA15 and m  9, g  2 for dsDNA19, dsDNA23, and dsDNA27.
The intrinsic binding constants (Kint) and cooperativity parameters ()
derived from computer fits are summarized in Table 3.
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3.7  0.2, respectively, suggesting that the binding of TraI to
FL-T25 and FL-dsDNA15 was accompanied with the net release
of about one and four ions, respectively (33). These results sug-
gest that electrostatic interactions are crucial for the stability of
TraI-DNA complex.Moreover, electrostatic interactions play a
more important role in the interaction of TraI with dsDNA.
Base Specificity of DNA Binding—Base specificity in interac-
tions of TraI with unlabeled ssDNA oligomers was addressed
using the MCT method (27). Titration of 50 nM FL-T17 with
TraI in the absence or presence of 250 nM unlabeled 25-mer
ssDNA (see Table 1 for the sequence) was performed (Fig. 7B).
This 25-mer ssDNA contains a mixture of four types of bases
and does not form any secondary structure or duplex under our
assay conditions. The presence of the 25-mer ssDNA shifted
the titration to a higher protein concentration, suggesting com-
petition between the 25-mer ssDNA and FL-T17 (Fig. 7B). A
model-independent binding isotherm for the 25-mer ssDNA
and subsequent analysis using Equation 9 under the condition
m  25 gave an intrinsic binding constant, Kint  8.7 (0.3)
106 M1 (Fig. 7C). Analogous titrations of FL-T17 in the pres-
ence of T25 or C25 indicate a pronounced shift in titration
curves (Fig. 7B). These data indicate that C25 and T25 compete
more efficiently with FL-T17 for TraI than does the 25-mer
ssDNA. Binding of TraI to T25 and C25 were characterized by a
Kint  2.5 (0.2) 107 and 5.8 (0.1) 107 M1, respectively.
These data indicate that TraI prefers to bind ssDNA oligomers
containing a single type of base, with a further preference for
pyrimidine oligomers. G25 was not examined here because it
tends to form a cruciform structure and is not easily synthe-
sized. The presence of A25 dramatically interfered with the fluo-
rescence anisotropy signal, making the titration curves in the
absence or presence of A25 incomparable. As a result, the bind-
ing constant for A25 was not determined by the MCT method.
Spatial Organization of the TraI Domains—Although the
crystal structures of several domains of TraI are available, there
is no known structure of a full-length TraI. To elucidate the
spatial organization of the TraI domains, we examined full-
length TraI by SAXS, which allows for the construction of a low
resolution structural envelope for a macromolecule. Many
important structural parameters, such as the radius of gyration
(Rg) and the maximum dimension (Dmax), can also be obtained
by analyzing the SAXS profile. The SAXS experiments were
performed on TraI solutions over a concentration range of
0.5–2mg/ml. The SAXS profile and the linearity of the Guinier
region indicated that TraI was well behaved and free of aggre-
gation (Fig. 8A). The Rg for TraI as obtained by the Guinier
approximation was 58.5  0.9 Å (Fig. 8A, inset). The Dmax of
TraIwas 220Å as determined from theP(r) function, calculated
using the program GNOM (Fig. 8B). The P(r) function reflects
the probable distribution of inter-atomic distances within the
FIGURE 5. Identification of the location of the dsDNA-binding site. A, titra-
tion of 50 nM FL-dsDNA15 with different TraI deletion mutants was performed
using the direct DNA binding assay in standard DNA binding buffer at 25 °C.
The solid lines are computer fits of the binding curves using a one-site binding
model (Equation 2). The macroscopic binding constants, KN, derived from the
computer fits are summarized in Table 4. B, competition of dsDNA and ssDNA
for the binding of TraI. Titration of a mixture of 100 nM FL-dsDNA15 and 100 nM
TraI with increasing concentration of 25-mer ssDNA, T25, was performed in
buffer A at 25 °C. The solid line is the computer fit of the curve using nonlinear
least square regression.
TABLE 3
Thermodynamic parameters of TraI binding to dsDNA oligomers of length ranging from 9 to 27 bp in buffer A at 25 °C
The following abbreviations are used: n,maximum stoichiometry; Kint, intrinsic binding constant; , cooperativity parameter; NA, not applicable.
dsDNA9 dsDNA11 DsDNA15 dsDNA19 DsDNA23 dsDNA27
n 1 1 1 2 2 2
Kint 105 (M 1) 9.9  7.9 4.7  0.2 5.1  0.2 5.2  0.5 6.2  0.3 5.4  0.4
 NA NA NA 18.1  3.8 38.6  7.7 14.8  2.2
TABLE 4
Macroscopic binding constants of different TraI constructs for FL-
dsDNA15 in standard DNA binding buffer at 25 °C
KN is the macroscopic binding constant.
TraI constructs KN  106
M1
1–1756 1.6  0.1
1–1476 0.78  0.7
1–858 1.1  0.1
1–330 0.02
302–1756 0.08  0.01
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scattering particles. The asymmetric feature of the P(r) func-
tion suggested that TraI exists in an elongated shape in
solution.
To better define the geometric shape of TraI, we performed
ab initio shape restoration of TraI using the program
DAMMIN (20). Forty independent runs were performed, and
initial parameters were intentionally varied between runs. In-
dependent runs generated very similar structural envelopes,
signifying consistency between different runs and reliability of
the generated structural envelopes. The 40 structural envelopes
were ranked based on their respective 2. The top 20 envelopes
(2 0.34) were averaged to generate the final SAXS envelope
that is 220  82  65 Å (Fig. 8C). The envelope features a
highly extended structure with two protuberances at each end
of the longest dimension. This structural envelope was used as
a guide for the determination of the spatial organization of TraI
domains in the following analysis.
In combination with atomic models, the structural envelope
generated from SAXS data can be used to determine the
domain organization of a multidomain protein. Although crys-
tal structures are available for the relaxase domain (residues
1–236 and 267–307) and part of theC-terminal domain (1476–
1628), atomic structures are missing for the rest of the protein.
We used the program PHYRE (23) to generate homology mod-
els for these two regions. The homology models of TraI 309–
842 and TraI 846–1473 were successfully generated by PHYRE
using the crystal structure of E. coliRecD (PDB entry, 1W36) as
a template. Due to the lack of homology, 56 and 74 residues are
missing from the final models of TraI 309–842 and TraI 846–
1473, respectively. Also, PHYRE failed to generate a model for
TraI 1629–1756 due to the lack of a homologous template. As a
result, the region encompassing residues 1629–1756 was not
incorporated into the following analysis.
A rigid body model of TraI was generated by manual place-
ment of TraI domains into the SAXS envelope. The flat and
extended shape of the TraI envelope, and the constraints of
inter-domain connectivity, allowed relatively little ambiguity in
determining the position of the four structural domains of TraI.
FIGURE 6. ADP and AMPPNP increased TraI affinity for ssDNA. Titration of 50 nM FL-T17 with TraI was performed in the absence or presence of 350 nM T25 in
buffer B (A), supplemented with 1 mM ADP (B) or 1 mM AMPPNP (C) at 25 °C. The solid lines are used to separate the data and do not have theoretical basis.
D, model-independent binding isotherms of TraI to T25 in the absence or presence of 1 mM ADP or AMPPNP. The binding density and the concentration of free
TraI were calculated from the titration curves in A–C using the MCT analysis (27). The solid lines are computer fits of the data using the Epstein combinatorial
approach (Equation 9) under the condition m  25. The intrinsic binding constants (Kint) for T25 in the absence of any nucleotide or in the presence of 1 mM ADP
or AMPPNP are 2.8 (0.4) 107, 1.2 (0.4) 108, and 1.4 (0.3) 108 M1, respectively.
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The crystal structure of the relaxase domain was manually
placed into the protuberance at one end of the envelope ini-
tially. Then homology models of the two RecD-like domains
were placed into the main body of the envelope, which was the
only portion of the envelope that could accommodate the com-
bined size of these two domains. Numerous positions and ori-
entations of these two RecD-like domains were examined to
minimize the discrepancy (2) between the calculated scatter-
ing intensities and the experimental scattering intensities. The
connectivity of contiguous domainswas used as a constraint for
placement. Finally, the crystal structure of the C-terminal
domain was modeled into the protuberance at the other end of
the envelope. Part of the envelope at the C-terminal end is
empty due to the missing of residues 1629–1756. The rigid
body model of TraI generated here has acceptable geometry
and gave a satisfactory 2 of 5.0 (Fig. 8A), especially considering
that 292 of 1756 residues are missing from the atomic models.
In our model, the four domains of TraI aligned along a single
axis, with the relaxase domain and the C-terminal domain at
the opposite ends, and the two RecD-like domains juxtaposed
in the middle (Fig. 8D).
DISCUSSION
TraIHas a Long ssDNA-binding Site—Most helicases require
the presence of a single-stranded tail for the unwinding of
duplex DNA. Typical superfamily I helicases, such as UvrD and
RecD, can efficiently unwind a duplex DNA with a single-
stranded tail of 10–12 nucleotides (34, 35). However, TraI
requires at least a 27-nucleotide tail for efficient unwinding and
cannot unwind duplex DNA if the tail is shorter than 20 nucle-
otides (36). Quantitative analysis in this work suggests that the
unusually long single-stranded tail required by TraI for DNA
unwinding arises from its unique ssDNA-binding properties.
TraI onlyweakly binds ssDNAoligomers shorter than 19 nucle-
otides, potentially explaining why TraI cannot unwind duplex
DNA when its single-stranded tail is shorter than 20 nucleo-
tides. Considering that the ssDNA-binding site of TraI can
encompass up to 25 nucleotides, and that, for optimal helicase
activity, the minimal single-stranded overhang requirement is
27 nucleotides, it appears that full engagement of the ssDNA-
binding site by DNA may trigger efficient DNA unwinding by
TraI.
TraI Binds to ssDNAwith LowCooperativity—TraI displayed
low cooperativity (  33.4  2.4) when binding to a ssDNA
oligomer that can accept twoTraImolecules, indicating that no
significant cooperative interactions existed between the two
bound TraI molecules. High cooperativity ( values between
102 and 105) is often associated with multimeric DNA-binding
proteins andproteinswhosemain function is to coverDNA (37,
38). Previous studies show that TraI functions as a processive
helicase in vitro (14). The low DNA binding cooperativity
FIGURE 7. Role of ionic strength and base specificity in TraI DNA binding.
A, dependence of binding affinity on NaCl concentration. 50 nM FL-T25 or
FL-dsDNA15 was titrated with TraI in buffer C supplemented with different
concentrations of NaCl as follows: 50, 75, 100, and 125 mM. The titration
curves are not shown here. The intrinsic binding constants, Kint, at different
NaCl concentrations were determined by fitting the titration curves using the
Epstein combinatorial approach (Equation 9). The data presented here are
averages from three independent experiments. The solid lines are linear least
square fit of the data. The slopes of the computer fits for FL-T25 and FL-
dsDNA15 are 1.2  0.2 and 3.7  0.2 respectively. B, binding of TraI to ssDNA
with different base compositions. Titration of 50 nM FL-T17 with TraI was per-
formed in the presence or absence of 250 nM 25-mer, T25, and C25, in standard
DNA binding buffer at 25 °C. The solid lines are used to separate the data and
do not have any theoretical basis. C, dependence of binding density on the
concentration of free TraI. The binding density and the concentration of free
TraI were calculated from the binding curve in B using the MCT analysis (27).
The solid lines are computer fits of the data using the Equation 9. The Kint for
25-mer, T25, and C25, are 8.7 (0.3) 10
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observed here supports the monomeric nature of TraI. Low
cooperativity during DNA binding is also associated withmany
other helicases and DNA-binding proteins that function as a
monomer, including helicase RecQ (39) and ssDNA-binding
protein ICP8 (40). It is interesting to note that the low cooper-
ativity during DNA binding might also reflect a physiological
adaptation of TraI to function as a single protein in the context
of the relaxosome. Many DNA helicases, which function as a
part of a large machinery, such as PriA and DnaB, have been
reported to display low cooperativity during DNA binding
(41–43).
dsDNA-binding Site Might Play a Role in the Assembly of the
Relaxosome—It is of interest to find that TraI can bind dsDNA
in the absence of any other protein in vitro. The intrinsic bind-
ing constant for dsDNA was determined to be about 5  105
M1 (Table 3), which is significantly lower than that for ssDNA
(Table 2). The low affinity of TraI for dsDNAmight explainwhy
TraI-dsDNA binding was not detected in the study by Matson
and co-workers (44), in which the highest TraI concentration
examined was 100 nM. Our deletion studies show that the
dsDNA-binding site is located at the N-terminal region (resi-
dues 1–858) of TraI and likely overlaps with the helicase-asso-
ciated ssDNA-binding site. Given that the affinity of TraI for
dsDNA is at least one order of magnitude lower than its affinity
for ssDNA, dsDNA binding will likely be outcompeted by
ssDNA binding when ssDNA, long enough to form stable com-
plex with TraI, is available. Therefore, we consider that this
dsDNA-binding site will not be engaged during the unwinding
of duplexDNAwhen a long stretch of ssDNA is available. How-
ever, this dsDNA-binding site might play a role in the assembly
of the relaxosome when ssDNA is not available. Biochemical
studies indicate that TraI alone can bind to a supercoiled
dsDNA that contains the oriT site in vitro (45). The interaction,
however, is sensitive to NaCl concentration and completely
FIGURE 8. Solution structure of TraI. A, SAXS profiles of TraI. The theoretical scattering profile of the rigid -body model for TraI (D) is shown by the red dashed
line. The inset is the Guinier plot of the experimental scattering profile. The solid lines are least square linear fits of the data under the condition Rg  q 1.3. B, P(r)
plot of TraI. The maximum dimension (Dmax) is derived to be 220 Å. C, DAMMIN model of the TraI shown in volumetric representation. D, DAMMIN model of TraI
superimposed with the atomic structures of the four structural domains of TraI (blue, the crystal structure of the relaxase domain residues 1–307, PDB entry
1P4D; yellow, the homology model of the RecD-like domain I, residues 310 – 844, from this work; pink, a homology model of the RecD-like domain II, residues
845–1476, from this work; green, the crystal structure of TraI 1476 –1628, PDB entry 3FLD).
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inhibited when the NaCl concentration is above 75 mM (44).
The binding of TraI to supercoiled dsDNA might be mediated
by the dsDNA-binding site identified here. Our observation
that the affinity of TraI to dsDNA is very sensitive to NaCl
concentration explains the sensitivity of relaxosome formation
to NaCl concentration.
SpatialOrganization of TraIDomains—TraI is a bifunctional
protein that contains four major structural domains. Under-
standing the spatial organization of these domains will provide
insight into the relative contribution of each domain to TraI
function. The SAXS-generated model of TraI reveals that the
protein assumes an extended shape in solution with the four
structural domains aligning along one axis. The relaxase
domain is located at one end of the model and creates a limited
number of contacts with the remainder of the protein (Fig. 8D).
This domain configuration provides the relaxase domain signif-
icant flexibility that is likely essential for the function of TraI.
The two RecD-like helicase domains aremodeled into themid-
dle of the SAXS envelope and together form multiple intimate
contacts, suggesting they may function as a unit. The CTD is at
the opposite end of the model relative to the relaxase domain,
consistent with the independent activities of these two
domains. The extended conformation of TraI allows for the
formation of contacts between each sequential domain of TraI,
as well as between TraI and other proteins. This network of
contacts may play a role in the regulation of the relaxase and
helicase activities of TraI.
A model of the TraI helicase in complex with a DNA sub-
strate containing a dsDNA-ssDNA junction was assembled
based on the SAXS envelope (Fig. 9). In this model, the location
of the dsDNA-ssDNA junction was determined based upon the
location of the “pin” domain, or subdomain 1B, of RecD-like
domain II, which has been proposed to contact duplex DNA in
structural studies of RecD proteins (46). The 5 ssDNA over-
hang binds to the long ssDNA binding groove formed by the
two RecD-like domains. Two possible end structures of the 5
ssDNA overhang are presented here. Based on the common
belief that one TraI molecule carries out both nicking at oriT
and ensuing duplexDNAunwinding, the 5 end of the ssDNA is
modeled as covalently attached to the relaxase domain. How-
ever, recent data from Schildbach and co-workers (47) suggest
nicking at oriT and ensuing duplex DNA unwinding could be
performed by two different TraI molecules; thus, we have also
modeled the ssDNA 5 end positioned away from the depicted
TraI, as it may be associated with another TraI (Fig. 9). In our
model, the 3 ssDNA overhang does not contact the protein
because we have found that the presence of a 3 ssDNA over-
hang does not enhance the affinity of TraI for DNA (Fig. 9).5
Contribution of RecD-like Domain I to the Processivity of TraI
Helicase—TraI functions as a highly processive monomeric
helicase (14). The helicase domain of TraI contains two RecD-
like domains, one with intact helicase motifs (domain II) and
one inwhich the helicasemotifs are not present (domain I) (Fig.
1) (17). Our SAXS model suggests that the two RecD-like
domains are closely associated with one another and may form
a continuous ssDNA binding groove. Similar domain organiza-
tion has been observed in the structure of themultimeric E. coli
helicase RecBCD (48). Alone, RecB is a monomeric 3–5 heli-
case with limited processivity. Similar to the RecD-like domain
I of TraI, RecC has a helicase-like fold but lacks both helicase
activity and key helicase motifs. Together, RecBC, a het-
erodimer formed by RecB and RecC, has significantly higher
processivity than RecD alone (48, 49). The crystal structure of
the complex clearly shows that the DNA-binding sites of RecB
and RecC are brought together in the heterodimer, forming a
long and continuous ssDNAbinding groove (48). The extended
binding groove likely facilitates the association of RecB with
ssDNA during translocation. We propose that in TraI, RecD-
like domain I functions as a processivity domain to assist the
motor domain, RecD-like domain II, in a manner analogous to
the RecBC complex.
AMPPNP and ADP Moderately Enhance the Affinity of TraI
for ssDNA—Helicases utilize the energy from NTP hydrolysis
to unwind nucleic acids. During each cycle of the NTPase reac-
tion, helicases process through a number of distinct nucleotide
binding states, including unbound, NTP-bound, and NDP-
bound. In current models, the transitions between nucleotide-
binding states during the NTPase reaction result in conforma-
tional changes in the nucleic acid-binding site of the helicase,
thereby driving the translocation of the helicase along the
nucleic acid (50). To understand how the conformational states
of TraI are controlled by its nucleotide-binding states, we
examined the effects of nucleotide concentration on the affinity
of TraI for ssDNA. Our data illustrate that the presence of
AMPPNP or ADP results in an approximate 3-fold increase in
ssDNA binding affinity by TraI. This indicates that TraI exists
in two distinct conformational states during each cycle of the
NTPase reaction. When the nucleotide-binding site is empty,
5 Y. Cheng and M. R. Redinbo, unpublished data.
FIGURE 9. Model of TraI association with a dsDNA-ssDNA junction. The
relaxase domain is shown in blue, the RecD-like domain I in yellow, the RecD-
like domain II in pink, and the C-terminal domain (CTD) in green. The two
strands of dsDNA are colored in orange and dark green. The four subdomains
(N-terminal domain (NTD), 1A, 2A, and 2B) of RecD-like domain I and the five
subdomains (N-terminal domain, 1A, 2A, 1B, and 2B) of RecD-like domain II
are shown and labeled. The known NTP-binding site is highlighted in red. In
this model, the 5 ssDNA overhang binds to the ssDNA binding groove mainly
formed by RecD-like domain I and RecD-like domain II. Two possible end
structures of the 5 ssDNA overhang, unattached or covalently attached to
the relaxase domain, are presented as dashed lines (47). The 3 ssDNA tail is
not bound by TraI. The dsDNA-ssDNA junction contacts subdomain 1B, or the
“pin” domain, of RecD-like domain II.
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TraI stays in a conformational state that has relatively low affin-
ity for ssDNA (the loose state). The binding of ATP switches
TraI into a conformational state that binds ssDNA with higher
affinity (the tight state). At the end of the cycle, TraI returns to
the loose state following the release of ADP. The presence of
different conformational states during each NTPase cycle has
been observed in most established helicases, although the
detailed mechanism can vary. For example, the helicase DnaB
exhibits 210-fold greater affinity for ssDNA upon NTP binding
(51), whereas nucleotide binding reduced the affinity of PriA for
ssDNA about 5-fold (43). Structural studies of SF1 helicases
have shown that nucleotide binding induces the close up of the
cleft between 1A and 2A domains (52–54). Given the high sim-
ilarity between the helicase domain of TraI and other SF1 heli-
cases, it is conceivable that TraI helicase may experience a sim-
ilar structural change upon nucleotide binding.
In summary, we have integrated biochemical and structural
data to provide the first comprehensive model of the interac-
tion of theTraI helicasewithDNA.Thismodel provides insight
into the mechanism of the TraI helicase and in particular sug-
gests how the TraI helicase can achieve such an exceptional
processivity through the cooperation of the two RecD-like
domains.
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